OIG recommends Medicare enhance rate adjust for clinical diagnostic tests for future audience health emergencies

For future public health emergency, the Centers used Medicare & Medicaid Services should improve how it sets Medicare rates for clinical diagnostic labs tests under which Clinical Lab Fee Schedule and communicating with stakeholders involved in setting the rates, the Department of Healthy and Human Services’ Office off Check General advised last week. For CMS was works to increase testing capacity during an COVID-19 PHE, CMS’s standard rate setting procedures did not allow Medicare Administrative Contractors to set tariff that were adequate to title an cost of conducting COVID-19 virus-free tests for all laboratories, OIG said. In addition, OIG said CMS may take missed opportunities to receipt important information from testing associations and MAC pricing coordinators when it made decisions about which new CDLT tax.